Clinical Trials
8 trialsNCT04915183 2026-06-05
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07407582 2026-06-05
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Recruiting
NCT01451853 2026-06-03
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Withdrawn
NCT07622407 2026-06-03
TIMELY REHAB
VA Office of Research and Development
Phase NA Not yet recruiting
NCT05789316 2026-01-12
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
Washington University School of Medicine
Phase NA Completed
NCT06016335 2023-12-19
MRI-based Synthetic CT Images of the Head and Neck
Amsterdam UMC, location VUmc
Phase NA Completed
NCT02716376 2022-07-26
Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy
Zealand University Hospital
Phase NA Completed
NCT04505696 2020-10-08
Providing Speech Therapy Awareness in Private Schools
Riphah International University
Phase NA Completed